Digital Infuzion, LLC

Digital Infuzion, LLC, a Rockville, Maryland-based minority-owned and Subcontinent Asian American-owned small business, delivers clinical research management systems, health IT infrastructure, data harmonization, and IT services to federal health agencies as a prime contractor (89% of recent awards) and as a subcontractor on larger health IT and clinical research programs. The company competes across mixed set-aside posture — roughly 40% of recent prime awards carry Total Small Business or Competitive 8(a) designations, while the remainder compete full-and-open on vehicle-wide awards and indefinite-delivery contracts.

Digital Infuzion's customer base concentrates heavily within the Department of Health and Human Services ecosystem. The top five customers by award count account for 47% of recent awards and are dominated by HHS sub-agencies: the National Institute of Allergy and Infectious Diseases (14 awards, $374.7 million combined potential value), the Health Resources and Services Administration (9 awards, $230.7 million), the NIH Clinical Center (8 awards, $1.2 million), NIAID sub-offices (8 awards, $5.4 million), and the National Center for Advancing Translational Sciences (6 awards, $53.1 million). By potential value, the concentration is even more pronounced: HHS NITAAC's Office of Information Technology Acquisition anchors the portfolio with 4 awards carrying $40.02 billion in combined potential value — this figure represents placeholder ceilings on the CIO-SP3 SB GWAC framework rather than expected spend, but it signals Digital Infuzion's institutional position within the government-wide IT procurement infrastructure for small businesses. The top five customers by dollars account for 99% of combined potential value.

Digital Infuzion's capability footprint centers on clinical research operations management, health data systems, and federal IT services. Representative work includes a $51.3 million delivery order from the National Institute of Allergy and Infectious Diseases for the Civics Data Management and Coordinating Center (DMCC) under the CIO-SP3 SB GWAC (September 2026, running through September 2033 on labor-hour pricing); a $110.999 million Clinical Research Management System (CRMS) support delivery order from NIAID under the GSA Multiple Award Schedule (September 2023, time-and-materials pricing); a $49.9 million single-award Indefinite Delivery Contract with the National Institute on Aging for centralized clinical research support services (March 2024, running through March 2029); and a $32.7 million contract from the National Institute on Drug Abuse for NCATS Clinical and Translational Science Awards Program coordination and operations support (September 2022, cost-plus-fixed-fee pricing). Ancillary work includes database maintenance (NCATS Inxight Drugs Fast Response Database), technical training application support (NIH Clinical Center), and data harmonization services for the NIH NeuroBioBank. The company holds positions on the GSA Multiple Award Schedule and the Federal Supply Schedule GS35F0701N in addition to its primary vehicle, the CIO-SP3 SB GWAC.

On CIO-SP3 SB, Digital Infuzion has placed 40 task orders valued at $388.9 million in combined potential value — the vehicle is a small-business-set-aside government-wide acquisition contract administered by GSA for IT services, and Digital Infuzion's 40-order footprint represents sustained institutional positioning within HHS health-research IT procurement. Additional vehicle positions include the GSA Multiple Award Schedule (7 task orders, $141.7 million combined potential value), the Federal Supply Schedule GS35F0701N (16 task orders, $13.8 million), and a Blanket Purchase Agreement under that schedule (9 task orders, $5.8 million).

SCI-reported invoiced revenue on prime federal service contracts shows steady growth: $21.8 million (80.9 FTEs) in FY2022 through $35.5 million (129 FTEs) in FY2025. Government-paid hourly rates on prime contracts span a median of $130.74 per hour, with the 10th percentile at $103.62/hr and the 90th percentile at $203.73/hr, reflecting a portfolio weighted toward mid-tier technical and project-management labor. Digital Infuzion's GSA Schedule labor portfolio spans 211 unique categories priced from $91.79/hr (Project Administrator II roles) through $434.07/hr (Software Architect roles with 16 years' experience), with substantial representation in health IT engineering, data architecture, and AI-adjacent technical categories at rates between $180–$310/hr. The company offers no security-cleared labor categories and requires no clearance posture across its current federal services footprint.

Across SCI-reportable prime contracts, subcontractors perform an average of 44% of total contractor hours, with 68 named subcontractors reported across the portfolio. Named subs include Deloitte Consulting LLP (cross-CTSA communication design and delivery on the NCATS CTSA Program support contract), ICF Incorporated (CTSA-wide meetings and conference management), Ctis Inc. (women-owned small business, clinical research management support), and recurring engagement with Rho Federal Systems Division Inc. on National Institute of Dental and Craniofacial Research clinical research operations and management support (document/information sharing, SAE/UP tracking, human subjects research management, and online training systems). Digital Infuzion also subcontracts to Rei Systems Inc. on HHS Health Resources and Services Administration EHB TVIS DME support work.

Activity has accelerated in recent years: 5 awards in FY2022, 3 in FY2023, 10 in FY2024, 4 in FY2025, and 4 in FY2026 (year-to-date through late September). Within the next twenty-four months, five awards with combined potential value of $200.7 million reach ultimate completion and face recompete exposure — these include the $6.8 million NIAID Statistical Data Management and Coordination Center delivery order (due May 2025), the NIH Clinical Center electronic training program maintenance order (due May 2027), and other smaller NCATS database maintenance work expiring in mid-2025. Digital Infuzion holds three sub-awards on clinical research and health IT programs: as a subcontractor to Rho Federal Systems Division Inc. on NIAID and National Institute of Dental and Craniofacial Research clinical research systems development (multiple task areas including document/information sharing, SAE/UP tracking, and human subjects research management systems); as a sub to Rei Systems Inc. on HHS HRSA EHB TVIS domain management and support; and as a sub to Gap Solutions Inc. on HHS Assistant Secretary for Planning and Evaluation IT systems administration and code map services software development support.

Digital Infuzion's federal footprint is narrowly specialized and customer-concentrated within HHS clinical research and health IT infrastructure — a positioning that reflects sustained institutional relationships with NIAID, NIA, NCATS, and related institutes but creates customer-concentration risk should HHS health-research IT budget priorities shift or incumbent vehicles be recompeted.

We provide information technology research and development solutions involving software applications design, development, and implementation in the specialized field of clinical trial management to both commercial and federal government clients.